Genome screen uncovers new targets for cancer immunotherapy
A new platform developed at Yale utilizes CRISPR technology to knock out genes individually and test which have the biggest impact on tumor response.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Cancer | Cancer & Oncology | Genetics | Health | Immunotherapy | Science | Universities & Medical Training | Yale